Susceptibility Test Plate, Antifungal
The Susceptibility Test Plate, Antifungal (product code NGZ) is an in vitro diagnostic device used to determine quantitative antifungal susceptibility of fungal organisms to various antifungal agents, guiding appropriate antifungal therapy selection, as described in its definition. It is classified as an FDA Class 2 device within the Microbiology specialty, requiring 510(k) premarket clearance. No specific regulation number has been assigned to this product code. The device is not flagged as an implant or life-sustaining device.
Research product code NGZ in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- NGZ
- Device Class
- FDA class 2
- Regulation Number
- 866.1640
- Medical Specialty
- Microbiology
- Review Panel
- MI
- Submission Type
- 1
Device Characteristics
Definition
The device is an in vitro diagnostic device intended for use in determining quantitative susceptibility of Candida species to various antifungal agents diluted in varying concentration in a microtiter plate format.
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 21 510(k) clearances via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K243738 | The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mL | Feb 27, 2025 | Substantially Equivalent | Thermo Fisher Scientific |
| K232967 | VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL) | Jun 12, 2024 | Substantially Equivalent | bioMerieux, Inc. |
| K232963 | VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL) | Jun 07, 2024 | Substantially Equivalent | bioMerieux, Inc. |
| K231433 | The Sensititre YeastOne Susceptibility System with Rezafungin in the dilution range of 0.008-8ug/mL | Aug 31, 2023 | Substantially Equivalent | Thermo Fisher Scientific |
| K221198 | Sensititre YeastOne Susceptibility System with Fluconazole in the dilution range of 0.12-128ug/mL | Mar 10, 2023 | Substantially Equivalent | Thermo Fisher Scientific |
| K221899 | The Sensititre YeastOne Susceptibility System with Caspofungin in the dilution range of 0.015-16ug/ml | Jan 20, 2023 | Substantially Equivalent | Thermo Fisher Scientific |
| K211539 | Sensititre YeastOne Susceptibility System with Voriconazole in the dilution range of 0.008 - 8 ug/mL | Dec 15, 2021 | Substantially Equivalent | Thermo Fisher Scientific |
| K181368 | VITEK 2 AST-YS Micafungin (<=0.06 - =>8 µg/mL) | Jun 20, 2018 | Substantially Equivalent | bioMerieux, Inc. |
| K151923 | VITEK 2 AST-Yeast Micafungin (0.06-8 mcg/mL) | Mar 25, 2016 | Substantially Equivalent | bioMerieux, Inc. |
| K151817 | VITEK 2 AST-YS Caspofungin <=0.125 - >=8 ug/mL | Feb 18, 2016 | Substantially Equivalent | bioMerieux, Inc. |
| K133952 | VITEK 2 AST YS FLUCYTOSINE, VITEK 2 AST YEAST FLUCYTOSINE | Aug 19, 2014 | Substantially Equivalent | bioMerieux, Inc. |
| K133817 | VITEK 2 AST - YEAST FLUCONAZOLE | Aug 05, 2014 | Substantially Equivalent | bioMerieux, Inc. |
| K133038 | SENSITITRE YEASTONE SUSCEPTIBILITY PLATES | Jan 31, 2014 | Substantially Equivalent | Trek Diagnostic Systems |
| K101566 | VITEK 2 YEAST CASPOFUNGIN | Sep 28, 2010 | Substantially Equivalent | bioMerieux, Inc. |
| K092454 | VITEK 2 YEAST VORICONAZOLE | May 21, 2010 | Substantially Equivalent | bioMerieux, Inc. |
| K082534 | ETEST VORICONAZOLE 0.002-32 UG/ML | Nov 02, 2009 | Substantially Equivalent | Ab Biomerieux |
| K090968 | SENSITITRE YEASTONE SUSCEPTIBILITY PLATES | Jun 04, 2009 | Substantially Equivalent | Trek Diagnostic Systems, Inc. |
| K081063 | SENSITITRE YEASTONE SUSCEPTIBILITY PLATES- ADDITIONAL ANTIMICROBICS | Mar 06, 2009 | Substantially Equivalent | Trek Diagnostic Systems, Inc. |
| K061945 | VITEK 2 AST-YS FLUCONAZOLE | Sep 19, 2006 | Substantially Equivalent | bioMerieux, Inc. |
| K040560 | ETEST FOR ANTIFUNGAL SUSCEPTTIBILITY TESTING | Jul 27, 2004 | Substantially Equivalent | Ab Biodisk |
| K991810 | MODIFICATION TO SENSITITRE YEASTONE MIC SUSCEPTIBILITY TEST | Oct 09, 2001 | Substantially Equivalent | Trek Diagnostic Systems, Inc. |
FEI Numbers
This FDA classification entry is associated with 8 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 8 registration numbers. Click on an entry to view related FDA registrations.